Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.

The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the...

Full description

Bibliographic Details
Main Authors: Joshua Park, Jacqueline Wicki, Sue E Knoblaugh, Jeffrey S Chamberlain, Donghoon Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4391935?pdf=render
id doaj-293910417b5c4072a6b7f4c1fb1aa928
record_format Article
spelling doaj-293910417b5c4072a6b7f4c1fb1aa9282020-11-25T02:15:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012491410.1371/journal.pone.0124914Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.Joshua ParkJacqueline WickiSue E KnoblaughJeffrey S ChamberlainDonghoon LeeThe objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx4cv mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.http://europepmc.org/articles/PMC4391935?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Joshua Park
Jacqueline Wicki
Sue E Knoblaugh
Jeffrey S Chamberlain
Donghoon Lee
spellingShingle Joshua Park
Jacqueline Wicki
Sue E Knoblaugh
Jeffrey S Chamberlain
Donghoon Lee
Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
PLoS ONE
author_facet Joshua Park
Jacqueline Wicki
Sue E Knoblaugh
Jeffrey S Chamberlain
Donghoon Lee
author_sort Joshua Park
title Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
title_short Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
title_full Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
title_fullStr Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
title_full_unstemmed Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
title_sort multi-parametric mri at 14t for muscular dystrophy mice treated with aav vector-mediated gene therapy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx4cv mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.
url http://europepmc.org/articles/PMC4391935?pdf=render
work_keys_str_mv AT joshuapark multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT jacquelinewicki multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT sueeknoblaugh multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT jeffreyschamberlain multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT donghoonlee multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
_version_ 1724896151201644544